☆ 4.3 Review

Empowering drug development: Leveraging insights from imaging technologies to enable the advancement of digital heath technologies

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2023)

Related references

Note: Only part of the references are listed.

Editorial Material Pharmacology & Pharmacy

Landscape Analysis of the Application of Artificial Intelligence and Machine Learning in Regulatory Submissions for Drug Development From 2016 to 2021

Qi Liu et al.

Summary: An increasing number of regulatory submissions for drug and biological products to the US Food and Drug Administration have included artificial intelligence/machine learning (AI/ML) from 2016 to 2021. AI/ML has been utilized for various tasks, including drug discovery/repurposing, clinical trial design, dose optimization, adherence to drug regimen, endpoint/biomarker assessment, and postmarketing surveillance. The exploration of AI/ML in facilitating drug development is growing.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

Add to Collection

Editorial Material Pharmacology & Pharmacy

Toward Bridging Unmet Medical Need in Early Alzheimer's Disease: An Evaluation of Beta-Amyloid (Aβ) Plaque Burden as a Potential Drug Development Tool

Hao Zhu et al.

Summary: This article discusses the potential use of reducing beta-amyloid (A beta) plaque as a tool for new drug development and improving access to therapies for Alzheimer's disease. By summarizing literature on seven anti-A beta antibodies, the article demonstrates a relationship between the extent of A beta plaque reduction and clinical improvements.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Add to Collection

News Item Multidisciplinary Sciences

NIH ISSUES A SEISMIC MANDATE: SHARE DATA PUBLICLY

Max Kozlov

Summary: The data-sharing policy has the potential to establish a global standard for biomedical research, according to scientists, but they have concerns regarding logistics and equity.

NATURE (2022)

Add to Collection

Review Behavioral Sciences

Emerging Role of Translational Digital Biomarkers Within Home Cage Monitoring Technologies in Preclinical Drug Discovery and Development

Szczepan W. Baran et al.

Summary: In drug discovery and preclinical research, remote digital monitoring technologies have emerged as valuable tools for assessing human patients and animal models. These technologies allow for continuous and non-invasive monitoring in familiar surroundings, providing more relevant and efficient diagnosis, as well as improved assessment of drug efficacy and safety. This review provides an overview of the history, evolution, and impact of digital monitoring technologies, and discusses barriers to implementation and strategies to overcome them.

FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2022)

Add to Collection

Article Chemistry, Analytical

Metadata Framework to Support Deployment of Digital Health Technologies in Clinical Trials in Parkinson's Disease

Derek L. Hill et al.

Summary: Digital health technologies generate valuable sensor data in clinical trials, but there is currently a lack of standardized methods to capture and store this data across different modalities and disease areas. This paper proposes a metadata framework that allows for pre-specification and standardization of the use of digital health technologies, promoting data comparability in future studies.

SENSORS (2022)

Add to Collection

Editorial Material Health Care Sciences & Services

Digital biomarkers: Convergence of digital health technologies and biomarkers

Srikanth Vasudevan et al.

Summary: The increasing digitization in healthcare has led to the development and adoption of Digital Health Technologies (DHT). The term 'digital biomarker' has been used to describe various measurements, and this study aims to align its meaning with established biomarker terminology and improve the assessment of scientific evidence for future digital biomarkers.

NPJ DIGITAL MEDICINE (2022)

Add to Collection

Article Health Care Sciences & Services

The economic imperatives for technology enabled wellness centered healthcare

Graham B. Jones et al.

Summary: A 2020 WHO report highlights the impact of increasing global healthcare spending and raises concerns about the long-term economic sustainability of current funding models. The rise in costs associated with late-stage irreversible diseases and the growing prevalence of neurodegenerative disorders, coupled with the increasing life expectancy, are expected to overwhelm healthcare systems in many countries within the next decade unless addressed. One potential solution is a shift from illness-centered care to wellness-centered care, with the P4 medicine approach as an attractive model. The integration of connected health technologies with conventional approaches can help accelerate this transition and guide public health policies towards wellness-based care models to alleviate the escalating economic burdens.

JOURNAL OF PUBLIC HEALTH POLICY (2022)

Add to Collection

Letter Genetics & Heredity

What role can decentralized trial designs play to improve rare disease studies?

J. Moore et al.

Summary: People affected by rare diseases want to be involved in research and the search for new treatments. Decentralized clinical trial (DCT) designs have become increasingly popular in rare disease trials, as they offer benefits in terms of patient burden, convenience, inclusion, and data quality. Digital tools also provide more convenient and environmentally valid measures of how a condition affects an individual's life.

ORPHANET JOURNAL OF RARE DISEASES (2022)

Add to Collection

Article Chemistry, Analytical

Sensor Verification and Analytical Validation of Algorithms to Measure Gait and Balance and Pronation/Supination in Healthy Volunteers

Robert Ellis et al.

Summary: This study aimed to verify the technical and analytical validity of Apple iPhone and ActiGraph GT9X accelerometers for measuring motor function in Parkinson's disease. The results suggest that these accelerometers are suitable for assessing the motor function of patients.

SENSORS (2022)

Add to Collection

Review Medicine, Research & Experimental

Fit-for-Purpose Biometric Monitoring Technologies: Leveraging the Laboratory Biomarker Experience

Alan Godfrey et al.

Summary: Biometric monitoring technologies (BioMeTs) and laboratory biomarkers share common features but also have unique characteristics that require bench and human experimentation testing phases. Digitally measured biomarkers require prospective data collection for analytical validation and lack widely accepted performance characteristics, necessitating standardized evaluation methods.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)

Add to Collection

Article Medicine, Research & Experimental

Remote FEV1 Monitoring in Asthma Patients: A Pilot Study

Chengrui Huang et al.

Summary: The study showed good compliance with repeated at-home mSpirometry in patients with moderate asthma, high agreement with clinic measurements, and comparable test-retest reliability. The technology demonstrated greater statistical power compared to clinic measurements, indicating its potential for use in asthma clinical research.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)

Add to Collection

Review Medicine, Research & Experimental

Digitally Enabled, Patient-Centric Clinical Trials: Shifting the Drug Development Paradigm

Marissa F. Dockendorf et al.

Summary: The rapidly advancing field of digital health technologies has the potential to revolutionize the way clinical trials are conducted. Merck's digitally enabled clinical trial initiative aims to reduce patient burden, improve drug adherence, and enhance data collection for more effective drug development.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)

Add to Collection

Editorial Material Oncology

Biometric Monitoring Technologies in Cancer: The Past, Present, and Future

Elena S. Izmailova et al.

JCO CLINICAL CANCER INFORMATICS (2021)

Add to Collection

Editorial Material Biotechnology & Applied Microbiology

Digital health technologies in clinical trials for central nervous system drugs: an EU regulatory perspective

Valentina Mantua et al.

Summary: Digital health technologies can help address challenges in the clinical development of drugs for central nervous system disorders. This article discusses strategies for developing such tools within the European regulatory environment.

NATURE REVIEWS DRUG DISCOVERY (2021)

Add to Collection

Review Clinical Neurology

A Review of Translational Magnetic Resonance Imaging in Human and Rodent Experimental Models of Small Vessel Disease

Michael S. Stringer et al.

Summary: MRI is crucial for detecting and understanding human SVD, and can also monitor SVD in rodent models, increasing the translational potential of the models. There is a need for greater utilization of MRI in rodent models, along with opportunities for harmonizing with human SVD MRI methods.

TRANSLATIONAL STROKE RESEARCH (2021)

Add to Collection

Review Neurosciences

Digital Health Technology to Measure Drug Efficacy in Clinical Trials for Parkinson's Disease: A Regulatory Perspective

Leonard Sacks et al.

Summary: Digital health technology provides new opportunities for measuring movement and functionality in Parkinson's disease, but accuracy and clinical significance are essential. Verification and validation of DHT performance are crucial to ensuring measurement accuracy and specificity.

JOURNAL OF PARKINSONS DISEASE (2021)

Add to Collection

Review Neurosciences

Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective

Diane Stephenson et al.

Summary: The burden of Parkinson's disease is increasing rapidly without objective biomarkers to measure disease progression; efforts to identify biomarkers have produced insights but robust disease progression biomarkers remain elusive; digital health technologies could complement traditional modalities in improving clinical research and therapeutic development.

JOURNAL OF PARKINSONS DISEASE (2021)

Add to Collection

Review Clinical Neurology

The Use, Standardization, and Interpretation of Brain Imaging Data in Clinical Trials of Neurodegenerative Disorders

Adam J. Schwarz

Summary: Imaging biomarkers play a crucial role in clinical trials for neurological disorders, helping to select trial participants, establish target engagement and mechanism-related pharmacodynamic effect, monitor safety, and provide evidence of disease modification. Standardized outcome measures improve the interpretation of disease-related imaging markers and comparability across different trials and imaging tools.

NEUROTHERAPEUTICS (2021)

Add to Collection

Article Medical Informatics

Value of Data Sharing to Advance Drug Development: A Regulatory Perspective

Aliza Thompson et al.

Summary: New tools are necessary for evaluating and predicting the efficacy and safety of medical products, but their development requires collaboration and effective data sharing. Scientists from C-Path discuss in Therapeutic Innovation & Regulatory Science their experiences using patient-level data to drive innovation in drug development. This paper provides insights and suggestions for future efforts in this area.

THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Temporal profiling of cytokines in passively expressed sweat for detection of infection using wearable device

Badrinath Jagannath et al.

Summary: This study demonstrates the potential of using passive sweat for tracking human body's inflammatory response, with the development of a wearable SWEATSENSER device for real-time monitoring of cytokines. The device shows high accuracy and specificity in detecting inflammatory markers, making it a promising tool for noninvasive tracking of host immune response biomarkers.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Clinical Neurology

The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectives

Christopher J. Weber et al.

Summary: The Worldwide Alzheimer's Disease Neuroimaging Initiative (WW-ADNI) is a global collaborative effort to investigate imaging and biofluid markers for Alzheimer's disease. Through longitudinal studies in different phases, researchers have advanced neuroimaging methodologies and standardized analyses, providing valuable data resources for other investigators.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2021)

Add to Collection

Editorial Material Medicine, Research & Experimental

Remote Monitoring in Clinical Trials During the COVID-19 Pandemic

Elena S. Izmailova et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)

Add to Collection

Article Medicine, Research & Experimental

The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD

Sravanthi Lavu et al.

JCI INSIGHT (2020)

Add to Collection

Review Medicine, Research & Experimental

An Evaluation of Biometric Monitoring Technologies for Vital Signs in the Era of COVID-19

Christine Manta et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)

Add to Collection

Article Chemistry, Analytical

Toward a Regulatory Qualification of Real-World Mobility Performance Biomarkers in Parkinson's Patients Using Digital Mobility Outcomes

Marco Viceconti et al.

SENSORS (2020)

Add to Collection

Article Medicine, General & Internal

Non-invasive Drug Monitoring of β-Lactam Antibiotics Using Sweat Analysis-A Pilot Study

Noe Brasier et al.

FRONTIERS IN MEDICINE (2020)

Add to Collection

Review Medicine, Research & Experimental

Biomarkers: Opportunities and Challenges for Drug Development in the Current Regulatory Landscape

Mariya Gromova et al.

BIOMARKER INSIGHTS (2020)

Add to Collection

Article Health Care Sciences & Services

Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs)

Jennifer C. Goldsack et al.

NPJ DIGITAL MEDICINE (2020)

Add to Collection

Article Medicine, Research & Experimental

Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's Disease

Klaus Romero et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2019)

Add to Collection

Article Peripheral Vascular Disease

Measurement of Blood Pressure in Humans A Scientific Statement From the American Heart Association

Paul Muntner et al.

HYPERTENSION (2019)

Add to Collection

Article Medicine, Research & Experimental

Continuous Monitoring Using a Wearable Device Detects Activity-Induced Heart Rate Changes After Administration of Amphetamine

Elena S. Izmailova et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2019)

Add to Collection

Article Oncology

Daily Step Counts: A New Prognostic Factor in Locally Advanced Non-Small Cell Lung Cancer?

Nitin Ohri et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

Add to Collection

Article Oncology

Daily step counts to predict hospitalizations during concurrent chemoradiotherapy for solid tumors.

Elena Izmailova et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

Add to Collection

Article Rheumatology

Very early MRI responses to therapy as a predictor of later radiographic progression in early rheumatoid arthritis

Philip G. Conaghan et al.

ARTHRITIS RESEARCH & THERAPY (2019)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Validated imaging biomarkers as decision-making tools in clinical trials and routine practice: current status and recommendations from the EIBALL* subcommittee of the European Society of Radiology (ESR)

Nandita M. deSouza et al.

INSIGHTS INTO IMAGING (2019)

Add to Collection

Review Pharmacology & Pharmacy

Wearable Devices in Clinical Trials: Hype and Hypothesis

Elena S. Izmailova et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)

Add to Collection

Review Pharmacology & Pharmacy

Digital Therapeutics: An Integral Component of Digital Innovation in Drug Development

Oleksandr Sverdlov et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)

Add to Collection

Article Clinical Neurology

The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort

Kenneth Marek et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)

Add to Collection

Article Medicine, Research & Experimental

Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis

Daniela J. Conrado et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)

Add to Collection

Article Rheumatology

The OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging (MRI) Scoring System: Updated Recommendations by the OMERACT MRI in Arthritis Working Group

Mikkel Ostergaard et al.

JOURNAL OF RHEUMATOLOGY (2017)

Add to Collection

Review Oncology

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

Lesley Seymour et al.

LANCET ONCOLOGY (2017)

Add to Collection

Article Urology & Nephrology

Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease

Ronald D. Perrone et al.

KIDNEY INTERNATIONAL REPORTS (2017)

Add to Collection

Article Oncology

RECIST 1.1-Update and clarification: From the RECIST committee

Lawrence H. Schwartz et al.

EUROPEAN JOURNAL OF CANCER (2016)

Add to Collection

Review Clinical Neurology

The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015

William J. Jagust et al.

ALZHEIMERS & DEMENTIA (2015)

Add to Collection

Review Clinical Neurology

The impact of the Alzheimer's Disease Neuroimaging Initiative 2: What role do public-private partnerships have in pushing the boundaries of clinical and basic science research on Alzheimer's disease?

Dorothy M. Jones-Davis et al.

ALZHEIMERS & DEMENTIA (2015)

Add to Collection

Article Biology

Quantification of gait parameters in freely walking rodents

Cesar S. Mendes et al.

BMC BIOLOGY (2015)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Metrology Standards for Quantitative Imaging Biomarkers

Daniel C. Sullivan et al.

RADIOLOGY (2015)

Add to Collection

Article Clinical Neurology

Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease

Derek L. G. Hill et al.

ALZHEIMERS & DEMENTIA (2014)

Add to Collection

Editorial Material Pharmacology & Pharmacy

Systems Pharmacology for Drug Discovery and Development: Paradigm Shift or Flash in the Pan?

P. Vicini et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)

Add to Collection

Article Clinical Neurology

MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials

Maria Pia Sormani et al.

LANCET NEUROLOGY (2013)

Add to Collection

Review Pharmacology & Pharmacy

Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival

Paul Morgan et al.

DRUG DISCOVERY TODAY (2012)

Add to Collection

Review Sport Sciences

Everything you wanted to know about selecting the right Actigraph accelerometer cut-points for youth, but ... : A systematic review

Youngwon Kim et al.

JOURNAL OF SCIENCE AND MEDICINE IN SPORT (2012)

Add to Collection

Article Biotechnology & Applied Microbiology

How to improve R&D productivity: the pharmaceutical industry's grand challenge

Steven M. Paul et al.

NATURE REVIEWS DRUG DISCOVERY (2010)

Add to Collection

Article Geriatrics & Gerontology

Physical activity of older Australians measured by pedometry

Ben Ewald et al.

AUSTRALASIAN JOURNAL ON AGEING (2009)

Add to Collection

Article Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. A. Eisenhauer et al.

EUROPEAN JOURNAL OF CANCER (2009)

Add to Collection

Review Medicine, Research & Experimental

The FDA critical path initiative and its influence on new drug development

Janet Woodcock et al.

ANNUAL REVIEW OF MEDICINE (2008)

Add to Collection

Article Clinical Neurology

Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results

Christopher G. Goetz et al.

MOVEMENT DISORDERS (2008)

Add to Collection

Article Oncology

New guidelines to evaluate the response to treatment in solid tumors

F Duffaud et al.

BULLETIN DU CANCER (2000)

Add to Collection

Article Oncology

New guidelines to evaluate the response to treatment in solid Tumors

P Therasse et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.